Fig. 4From: Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways a Prohibitin expression in borderline serous tumor. (IHC; ×40). b Expression of prohibitin in borderline mucinous tumor. (IHC; ×40)Back to article page